Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

ADPT | NASDAQ
Chart Builder DCF Calculator
$27.86
-$0.75 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$28.06
+$0.20 (+0.72%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$4.58B
Enterprise Value
$4.53B
Beta
2.10
Average Volume
2.59M
Shares Outstanding (Diluted)
157.7M
Shares Change YoY
3.69%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US00650F1093

Price Performance

Price Change 1M
7.9%
Price Change 3M
-59.6%
Price Change 6M
-50.8%
Price Change YTD
-56.2%
Price Change 1Y
-50.0%
Price Change 3Y
37.4%
Price Change 5Y
-80.9%
1M CAGR (ann.)
21.2%
1Y CAGR (ann.)
123.2%
5Y CAGR (ann.)
-5.6%
All-Time CAGR
-4.6%

Valuation

PE Ratio
-67.95
Forward PE
N/A
PEG Ratio
-1.39
Forward PEG
1.04
PS Ratio
14.47
Forward PS
12.40
PB Ratio
31.20
P/FCF Ratio
-185.52
P/Adj. FCF Ratio
-74.56
P/OCF Ratio
-214.31
EV/Sales
14.69
EV/EBIT
-140.99
EV/EBITDA
-283.49
EV/FCF
-188.28
Earnings Yield
-1.5%
FCF Yield
-0.5%
Adj. FCF Yield
-1.3%

Financial Health

Net Cash
$556K
Total Debt
$410.5M
Cash & Short-Term Investments
$344.26M
Total Assets
$640.68M
Current Ratio
4.79
Quick Ratio
4.68
Debt / Equity Ratio
2.87
Debt / EBITDA
-25.72
Debt / FCF
-17.08
OCF / Debt
-0.05
Interest Coverage
-3.26
Altman Z-Score
3.44
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
75.4%
Operating Profit Margin
-12.2%
EBITDA Margin
-5.2%
Net Profit Margin
-20.7%
FCF Margin
-7.8%
Adj. FCF Margin
-19.4%
SBC / Revenue
11.6%
SBC Impact (per share)
-148.8%

Returns

Return on Assets
-10.0%
Return on Equity
-32.6%
Return on Invested Capital
-6.7%
Return on Capital Employed
-6.8%
Return on Tangible Assets
-12.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
17.6%
Revenue CAGR 5Y
18.2%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
58.9%
EPS CAGR 5Y
25.6%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
69.4%
FCF CAGR 5Y
39.8%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
17
EPS Growth Next 3Y
52.0%
Revenue Growth Next 3Y
20.9%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.10
EPS Growth Est (next Q)
-266.7%
Revenue Est (next Q)
$71.65M
Revenue Growth Est (next Q)
-23.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$24.38
Price Target Upside
-12.5%

Cash Flow

Operating Cash Flow
$-21.01M
Free Cash Flow
$-24.03M
Adj. Free Cash Flow
$-59.8M
FCF Per Share
-$0.15
OCF Per Share
-$0.13
OCF/S Ratio
-6.8%

Income Statement

Revenue
$308.08M
Gross Profit
$232.4M
Operating Income
$-37.46M
EBITDA
$-15.96M
Net Income
$-63.85M
EPS (Diluted)
-$0.41
Revenue / Employee
$493.72K
Profit / Employee
$-102.33K
Employees
624

© 2026 bestshares.com. All rights reserved.